Company Overview of OctoPlus N.V.
Key Executives for OctoPlus N.V.
|Jan Hendrik Egberts M.D., Ph.D.||77 Relationships||Chief Executive Officer and Member of Executive Board||56|
|Susan M. Swarte||4 Relationships||Chief Financial Officer and Member of Executive Board||46|
OctoPlus N.V. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)||32 Relationships||Dr. Reddy's Laboratories Ltd.||56|
|Daan Crommelin Ph.D.||10 Relationships||AGLAIA BioMedical Ventures B.V.||--|
|Douwe D. Breimer Ph.D.||20 Relationships||Life Sciences Partners BV||--|
|W. E. Hennink||7 Relationships||OctoPlus N.V.||--|
|Peter van Brummelen Ph.D., M.D.||15 Relationships||Enceladus Pharmaceuticals BV||73|
OctoPlus N.V. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Supervisory Board B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)||Gunupati Venkateswara Prasad||32 Relationships||3 Executives|
|Advisory Board Ph.D.||Daan Crommelin||10 Relationships||5 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$668.0K|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.